Chione Ltd - Net Worth and Insider Trading
Chione Ltd Net Worth
The estimated net worth of Chione Ltd is at least $35 Million dollars as of 2024-11-05. Chione Ltd is the 10% Owner of Acrivon Therapeutics Inc and owns about 3,848,632 shares of Acrivon Therapeutics Inc (ACRV) stock worth over $30 Million. Chione Ltd is also the 10% Owner of Karyopharm Therapeutics Inc and owns about 6,000,000 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $5 Million. Details can be seen in Chione Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chione Ltd has not made any transactions after 2023-06-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chione Ltd
Chione Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chione Ltd owns 2 companies in total, including Karyopharm Therapeutics Inc (KPTI) , and Acrivon Therapeutics Inc (ACRV) .
Click here to see the complete history of Chione Ltd’s form 4 insider trades.
Insider Ownership Summary of Chione Ltd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2019-02-28 | 10 percent owner |
| ACRV | Acrivon Therapeutics Inc | 2023-06-26 | 10 percent owner |
Chione Ltd Latest Holdings Summary
Chione Ltd currently owns a total of 2 stocks. Among these stocks, Chione Ltd owns 3,848,632 shares of Acrivon Therapeutics Inc (ACRV) as of June 26, 2023, with a value of $30 Million and a weighting of 84.94%. Chione Ltd also owns 6,000,000 shares of Karyopharm Therapeutics Inc (KPTI) as of February 28, 2019, with a value of $5 Million and a weighting of 15.06%.
Latest Holdings of Chione Ltd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics Inc | 2023-06-26 | 3,848,632 | 7.82 | 30,096,302 |
| KPTI | Karyopharm Therapeutics Inc | 2019-02-28 | 6,000,000 | 0.89 | 5,336,400 |
Holding Weightings of Chione Ltd
Chione Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, Chione Ltd has made a total of 4 transactions in Acrivon Therapeutics Inc (ACRV) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Acrivon Therapeutics Inc is the sale of 16 shares on June 26, 2023, which brought Chione Ltd around $207.
According to the SEC Form 4 filings, Chione Ltd has made a total of 0 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 149,624 shares on February 28, 2019, which brought Chione Ltd around $619,443.
Insider Trading History of Chione Ltd
- 1
Chione Ltd Trading Performance
GuruFocus tracks the stock performance after each of Chione Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chione Ltd is 37.34%. GuruFocus also compares Chione Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chione Ltd within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chione Ltd's insider trading performs compared to the benchmark.
Performance of Chione Ltd
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -23.73 | | | | | |
| Relative Return to S&P 500(%) | -21.34 | | | | | |
Chione Ltd Ownership Network
Ownership Network List of Chione Ltd
Ownership Network Relation of Chione Ltd
Chione Ltd Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Chione Ltd is the 10 percent owner of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & CFO & Treasurer Michael Mason , and SVP Sales & Commercial Ops Sohanya Roshan Cheng .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Chione Ltd made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 162,007 shares made by Richard A. Paulson , a net sale of 55,845 shares made by Michael Mason , and a net sale of 41,559 shares made by Sohanya Roshan Cheng .
In summary, during the past 3 months, insiders sold 27,259 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 27,259 shares. During the past 18 months, 2,074,507 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,033,367 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Chione Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Chione Ltd. You might contact Chione Ltd via mailing address: Simou Menardou 8, Ria Court 8, Office 101, 6015, Larnaca G4 Cy.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
